Review of Scoring Systems for Hidradenitis Suppurativa
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hidradenitis suppurativa (HS) is an inflammator y disorder characterized by chronic deep- seated nodules, abscesses, fistulae, sinus tracts, and scars in apocrine gland-bearing regions. Assessing its severity is challenging because of its clinical heterogeneity, lack of a standardized tool, and increasing severity scores. This article provides a chronological over view of HS grading scales to aid in the understanding and comparison of different scoring systems. A literature review of articles published in English on PubMed was conducted searched from 1989 to 2023. The review includes 15 scores that are the most relevant and widely used and acknowledges the existence of over 30 scoring systems for HS. The expanding landscape of HS scoring systems presents challenges when patients evaluated using different systems are compared. A universally accepted scoring system is required for consistent application across diverse populations. A comprehensive assessment should balance subjective and objective items, considering obser ver-reported signs and patient-reported symptoms to make meaningful treatment decisions.
Abstract
Hidradenitis suppurativa (HS) is an inflammator y disorder characterized by chronic deep- seated nodules, abscesses, fistulae, sinus tracts, and scars in apocrine gland-bearing regions. Assessing its severity is challenging because of its clinical heterogeneity, lack of a standardized tool, and increasing severity scores. This article provides a chronological over view of HS grading scales to aid in the understanding and comparison of different scoring systems. A literature review of articles published in English on PubMed was conducted searched from 1989 to 2023. The review includes 15 scores that are the most relevant and widely used and acknowledges the existence of over 30 scoring systems for HS. The expanding landscape of HS scoring systems presents challenges when patients evaluated using different systems are compared. A universally accepted scoring system is required for consistent application across diverse populations. A comprehensive assessment should balance subjective and objective items, considering obser ver-reported signs and patient-reported symptoms to make meaningful treatment decisions.
참고문헌 (19)
- Goldburg SR, "Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis", J Am Acad Dermatol, 82, pp.1045~1058 (2020)
- Saunte DML, "Hidradenitis suppurativa : advances in diagnosis and treatment", JAMA, 318, pp.2019~2032 (2017)
- Hurley HJ, "Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus: surgical approach" (1989), Marcel Dekker
- Horváth B, "Hurley staging refined : a proposal by the Dutch hidradenitis suppurativa expert group", Acta Derm Venereol, 97, pp.412~413 (2017)
- Sartorius K, "Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa", Br J Dermatol, 149, pp.211~213 (2003)
- Sartorius K, "Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity", Br J Dermatol, 161, pp.831~839 (2009)
- Grant A, "Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial", J Am Acad Dermatol, 62, pp.205~217 (2010)
- Kimball AB, "Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa : a parallel randomized trial", Ann Intern Med, 157, pp.846~855 (2012)
- Kimball AB, "HiSCR(Hidradenitis Suppurativa Clinical Response) : a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study", J Eur Acad Dermatol Venereol, 30, pp.989~994 (2016)
- Chiricozzi A, "AISI : a new disease severity assessment tool for hidradenitis suppurativa", Wounds, 27, pp.258~264 (2015)
- Zouboulis CC, "Development and validation of the international hidradenitis suppurativa severity score system (IHS4), a novel dynamic scoring system to assess HS severity", Br J Dermatol, 177, pp.1401~1409 (2017)
- Tzellos T, "Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa", J Eur Acad Dermatol Venereol, 37, pp.395~401 (2023)
- Hessam S, "A novel severity assessment scoring system for hidradenitis suppurativa", JAMA Dermatol, 154, pp.330~335 (2018)
- Goldfarb N, "Hidradenitis suppurativa area and severity index revised(HASI-R) : psychometric property assessment", Br J Dermatol, 184, pp.905~912 (2021)
- Kirby JS, "Severity and area score for hidradenitis(SASH) : a novel outcome measurement for hidradenitis suppurativa", Br J Dermatol, 182, pp.940~948 (2020)
- Goldfarb N, "Hidradenitis suppurativa area and severity index(HASI) : a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa", Br J Dermatol, 182, pp.240~242 (2020)
- Marzano AV, "Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure : the HIDRAscore", J Eur Acad Dermatol Venereol, 34, pp.1815~1821 (2020)
- Seyed Jafari SM, "A retrospective cohort study on patients with hidradenitis suppurativa", Dermatology, 234, pp.71~78 (2018)
- Garg A, "Development and initial validation of the HS-IGA : a novel hidradenitis suppurativa-specific investigator global assessment for use in interventional trials", Br J Dermatol, 187, pp.203~210 (2022)